In future studies, to better simulate the process of binding of SARS-CoV-2 to the ACE2 receptor in the body, our research team will continue to design and express the trimeric S protein to further optimize the immune analysis system to more accurately meet the post-pandemic era COVID-19 demand for neutralizing antibody testing brought about by large-scale medical treatment. This evidence concerns the gene PROS1 and COVID-19.